HOSPITAL PERFORMANCE IN THE TREATMENT OF ST ELEVATION MYOCARDIAL INFARCTION CORRELATES WITH OVERALL ADHERENCE TO EVIDENCED BASED CARE IN THE TREATMENT OF ACUTE CORONARY SYNDROMES IN THE AUSTRALIAN COOPERATIVE NATIONAL REGISTRY OF ACUTE CORONARY CARE, GUIDELINE ADHERENCE AND CLINICAL EVENTS CONCORDANCE  by Aliprandi-Costa, Bernadette et al.
A147
JACC April 1, 2014
Volume 63, Issue 12
Acute Coronary Syndromes
hoSpital perFormanCe in the treatment oF St elevation myoCardial inFarCtion 
CorrelateS With overall adherenCe to evidenCed baSed Care in the treatment oF 
aCute Coronary SyndromeS in the auStralian Cooperative national regiStry oF aCute 
Coronary Care, guideline adherenCe and CliniCal eventS ConCordanCe
Poster Contributions
Hall C
Sunday, March 30, 2014, 9:45 a.m.-10:30 a.m.
Session Title: Acute Coronary Syndromes: STEMI
Abstract Category: 1. Acute Coronary Syndromes: Clinical
Presentation Number: 1190-232
Authors: Bernadette Aliprandi-Costa, David Brieger, Karice Hyun, Darren Walters, Sandra West, Janice Gullick, Victoria Miller, Isuru Ranasinghe, 
Concord Hospital, Sydney, Australia, Sydney University, Sydney, Australia
background:  Adherence to process of care measures is variable in Australian Hospitals. We sought to determine if ST elevation MI (STEMI) 
performance measures were associated with adherence to other clinical process measures (CPI) and to describe the relationship between 
performance in process measures and clinical events.
methods: 17 hospitals participating in the CONCORDANCE Registry from 2009-2013 enrolled 3163 patients with STEMI (n=1048), Non ST acute 
coronary syndrome (NSTEACS) (n=1553) and unstable angina (UA) (n=562). Hospitals were ranked for adherence to STEMI system measures 
1) provision and 2) timely access to reperfusion for STEMI and stratified into quartiles. Logistic regression modelling was used to determine the 
association between adherence to system process measures and 3 CPI’s: timely access to coronary angiography for high risk ACS, receipt of 4 or 
more evidenced based therapies; aspirin, antiplatelets, B-blocker, statin, ACE or ARB and referral to secondary prevention. In hospital events and 
mortality at 6mths (adjusted for Grace Risk score) were compared.
results: Hospitals ranked in the upper 2 quartiles for STEMI system performance performed better than hospitals in the lower quartiles for 
adherence to clinical process measures 72.8% vs 62.1% p=0.0024. Patients in the upper ranked hospitals had a higher GRACE risk score (135 vs 
131 p=0.0016) and experienced more in-hospital CCF (OR 1.5 95% CI 1.1- 2.1); MI (OR 2.2 95% CI 1.3-3.7); renal failure (OR 3.1 95% CI 2.0-4.6) 
and ischaemia (OR 1.5 95% CI1.1-1.9). The median length of stay was 4 days for both groups and there was no difference in hospital mortality. 
There was a trend towards less death in the higher ranked hospitals at 6 months (adjusted OR 0.6 95%CI 0.4-1.1) p=0.1005. 
Conclusions: Variation in adherence to system and clinical process measures persist. Hospitals that adhere to STEMI system measures perform 
well in other clinical process measures, treat more high risk patients and attend to more in-hospital cardiovascular events effectively without a delay 
in hospital length of stay. Addressing system level barriers may improve adherence to all clinical process measures and patient outcomes.
